Pancreatic cancer
2020 · The Lancet · 2,412 citations
https://doi.org/10.1016/s0140-6736(20)30974-0
R
Rachna T. Shroff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
384
Papers
16.6K
Citations
48
h-index
115
i10-index
Rachna T. Shroff is an academic researcher from American Cancer Society. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cholangiocarcinoma and Gallbladder Cancer Studies & Cancer Genomics and Diagnostics. The author has an h-index of 48, co-authored 327 publications.
ORCID: 0000-0003-0066-2672Papers by this author
worksIntegrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
2017 · Cancer Cell · 1,985 citations
https://doi.org/10.1016/j.ccell.2017.07.007
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
2020 · The Lancet Oncology · 995 citations
https://doi.org/10.1016/s1470-2045(20)30157-1
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
2017 · Cell Reports · 599 citations
https://doi.org/10.1016/j.celrep.2017.02.033
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
2019 · JAMA Oncology · 460 citations
https://doi.org/10.1001/jamaoncol.2019.0270
HER2/neu-directed therapy for biliary tract cancer
2015 · Journal of Hematology & Oncology · 220 citations
https://doi.org/10.1186/s13045-015-0155-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat